Delivery Order SPE2DE24D0013-SPE2D625F8BS6
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,913.79 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 13, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The contract is structured as a delivery...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 15, 2025, with completion scheduled for August 22, 2025. The delivery order, designated 4569128836 for XPCOV2/FLU/RSV-10 diagnostic solutions, carries no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. This award represents procurement of molecular diagnostic testing capabilities, specifically for detection of...
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,925 firm fixed-price delivery order to Cepheid Inc. on August 13, 2025, with an ultimate completion date of August 20, 2025. The contract, identified as XPRSARS-COV2-10, represents a delivery order under a larger vehicle and carries no set-aside designation. Work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,174.64 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, has an ultimate completion date of July 30, 2025, and carries no set-aside designation. The contract references diagnostic testing for COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- On August 8, 2025, the Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic solutions. The delivery order, identified as XPRS4PLEX-10 with contract number 4569031069, requires completion by August 15, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8BS6Delivery Order
The Defense or Civilian agency within Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 22, 2025, with an ultimate completion date of July 29, 2025. This contract, identified as XPRSARS-COV2-10, involves delivery of molecular diagnostic solutions to the Sunnyvale, California location. The award carries no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid is a for-profit molecular diagnostics manufacturer specializing in GeneXpert diagnostic systems and associated test kits for infectious diseases, including COVID-19, influenza, and respiratory syncytial virus. The company maintains established relationships across multiple federal healthcare systems, including the Veterans Integrated Service Networks, Defense Logistics Agency, and Defense Health Agency. This delivery order aligns with Cepheid's core federal business of providing PCR testing reagents, assays, and diagnostic equipment to support laboratory microbiology and infectious disease detection across the federal healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 7/22/25 |